Live News Categoriesmarket

9688 (9688) News

Follow 9688 (9688) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 9688 Asset market Sector Markets 90 days 1 Updated Sep 29, 2026, 11:01 AM UTC Open live news feed

L Zai Lab to Present First Global Data from Clinical Trial Evaluating Zocilurtatug Pelitecan (Zoci) As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Zai Lab Limited (NASDAQ:ZLAB; HKEX:9688) today announced that global data from a clinical trial evaluating zocilurtatug pelitecan (zoci, formerly ZL-1310) for the first-line treatment of extensive-stage small cell lung c NEWS | Sep 29, 2026, 11:01 AM UTC